SBIG vs ZUKI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBIG is a Sell and ZUKI is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SBIG’s FA Score shows that 0 FA rating(s) are green whileZUKI’s FA Score has 1 green FA rating(s).
- SBIG’s FA Score: 0 green, 5 red.
- ZUKI’s FA Score: 1 green, 4 red.
Price Growth
SBIG (@Packaged Software) experienced а -39.94% price change this week, while ZUKI (@Packaged Software) price change was -4.89% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was +3.23%. For the same industry, the average monthly price growth was +7.15%, and the average quarterly price growth was +5.72%.
Reported Earning Dates
SBIG is expected to report earnings on Mar 06, 2025.
Industries' Descriptions
@Packaged Software (+3.23% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
| SBIG | ZUKI | SBIG / ZUKI | |
| Capitalization | 7.95M | 6.57M | 121% |
| EBITDA | -9.83M | -165.19K | 5,951% |
| Gain YTD | -59.705 | 117.353 | -51% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 28.4M | 0 | - |
| Total Cash | 726K | 91 | 797,802% |
| Total Debt | 5.24M | 74.7K | 7,008% |
ZUKI | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 14 Undervalued | |
PROFIT vs RISK RATING 1..100 | 87 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 39 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IVOIX | 20.51 | -0.15 | -0.73% |
| Delaware Ivy Mid Cap Income Opps I | |||
| RWIGX | 67.23 | -0.72 | -1.06% |
| American Funds Capital World Gr&Inc R6 | |||
| FAOSX | 32.94 | -0.42 | -1.26% |
| Fidelity Advisor Overseas Z | |||
| TSRPX | 20.79 | -0.33 | -1.56% |
| Nuveen Quant Small Cap Equity Premier | |||
| RYCFX | 49.93 | -2.32 | -4.44% |
| Rydex Biotechnology C | |||
SBIG and
Correlation & Price change
A.I.dvisor indicates that over the last year, SBIG has been loosely correlated with MAPS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SBIG jumps, then MAPS could also see price increases.
| Ticker / NAME | Correlation To SBIG | 1D Price Change % | ||
|---|---|---|---|---|
| SBIG | 100% | +50.00% | ||
| MAPS - SBIG | 35% Loosely correlated | -0.79% | ||
| RELY - SBIG | 30% Poorly correlated | -0.96% | ||
| PYCR - SBIG | 29% Poorly correlated | -4.07% | ||
| CIOXY - SBIG | 29% Poorly correlated | N/A | ||
| MANH - SBIG | 29% Poorly correlated | -2.55% | ||
More | ||||
ZUKI and
Correlation & Price change
A.I.dvisor tells us that ZUKI and PBSV have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZUKI and PBSV's prices will move in lockstep.
| Ticker / NAME | Correlation To ZUKI | 1D Price Change % | ||
|---|---|---|---|---|
| ZUKI | 100% | N/A | ||
| PBSV - ZUKI | 21% Poorly correlated | N/A | ||
| SDCH - ZUKI | 10% Poorly correlated | +2.05% | ||
| LIFW - ZUKI | 6% Poorly correlated | -20.87% | ||
| SBIG - ZUKI | 6% Poorly correlated | +50.00% | ||
| LSPKF - ZUKI | 3% Poorly correlated | N/A | ||
More | ||||